New Intelerad Research Shows 64 Percent of U.S. Consumers Highly Trust Artificial Intelligence (AI) for Medical Imaging
The new study examines over 1,000 patient attitudes toward AI and how it’s being used to support patient care
The new study examines over 1,000 patient attitudes toward AI and how it’s being used to support patient care
Company names AJ Watson as Chief Product Officer and Paul Johnson as Chief Delivery Officer to drive continued growth among the company’s global client base
Industry-Leading Software Suite Enables Clients to Centralize Patient Data, Achieve Interoperability and Improve Patient Outcomes
Ambra Health, an Intelerad Company, named Best in KLAS for Image Exchange for 8th Consecutive Year. Read the full press release here.
Ambra Health, an Intelerad Company, named Best in KLAS for Image Exchange for 8th Consecutive Year
Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, and Ambra Health, an Intelerad Company, and maker of a
Partnership brings together leading innovators in the medical imaging and diagnostics space to advance the promise of point-of-care ultrasound across hospitals and health systems
With over 20 years of industry expertise, seasoned executive joins the company to support rapid growth and expansion of imaging and informatics solutions for clients
Company completed four acquisitions in 2021, with a total of six new acquisitions since investment from HG Capital in February 2020
Collaboration Between the Leading AI Provider and Leading Image Exchange Network to Advance Imaging AI Interoperability Across the Healthcare Ecosystem BOSTON, MA – November 30,
© 2021 Intelerad Medical Systems Incorporated. All rights reserved.